Core Biomedicine Raises $21M Series A to Advance Precision Oncology Pipeline

Boston-based Core Biomedicine has raised $21 million in Series A financing co-led by UTokyo Innovation Platform and Elikon Venture and... Read More

The post Core Biomedicine Raises $21M Series A to Advance Precision Oncology Pipeline appeared first on citybiz.